Moderna Stock Jumps on Canadian Government's Approval of Updated COVID-19 Vaccine
Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 vaccine.Moderna's Spikevax KP.2 targets the KP.2 variant of the virus.The U.S. Food and Drug Administration has also approved the shot,
COVID-19 2024 fall guide: Everything Canadians should know about new Moderna vaccine, current variants and more
NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in the fall of 2024." The organization recommends a six-month interval between COVID vaccines, "with a minimum of three months from the last dose."
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians
GIANT announces updated COVID-19 vaccines
The GIANT Company announced that updated 2024-2025 COVID-19 vaccines are available. Moderna’s Spikevax and Pfizer’s Comirnaty are available for those 12-years and older at GIANT and MARTAIN’S pharmacies.
Moderna Gets Canada Approval for Updated Covid-19 Vaccine
The biotechnology company on Tuesday said that Health Canada authorized the vaccine targeting the KP.2 Covid-19 variant of Sars-Cov-2. Moderna will begin delivery of updated doses to the Public Health Agency of Canada,
Be warned: Check your insurance before getting a COVID-19 vaccine this year
The Centers for Disease Control and Prevention says that the Federal Drug Administration has ended a program that provided ...
Moderna: Still Bullish View
Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
Moderna lays out plan to slice research and development spending
Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...
Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans
Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...
Updated COVID-19 vaccines now available at GIANT and MARTIN’S in-store pharmacies in Pennsylvania
The GIANT Company announced today that updated 2024-2025 COVID-19 vaccines are now available in all GIANT and MARTIN’S ...
UK, Taiwan Approve Moderna's Updated COVID-19 Shot
For the first time in the U.K., the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those ...